RxDoctor Payments Data

Carlos Santos, MD

Obstetrics & Gynecology · West Seneca, NYNPI 1275526246

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Therapeuticsmd, Inc. at 50.8% of the total. Reporting peaked in 2021 at $124 and has fallen 70.7% since, to $36 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in NY, where the typical reported total is $302.

$245in general payments, 2019–2025

Across 7 payments — averaging $34.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Therapeuticsmd, Inc.$124
  • GE HealthCare$47
  • Gilead$24
  • Merck$23
  • Coopersurgical, Inc.$14
  • Organon$13
$261,848in research payments, 2019–2025

Across 74 payments — averaging $3538.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$180K
  • Incyte Corporation$31K
  • Ferring International Pharmascience Center US$28K
  • Evofem Biosciences, Inc.$18K
  • Bayer$6K

What the payments were for

  • Food & beverage$245100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$245 in reported general payments places this provider in the 45th percentile of 2,673 obstetrics & gynecology providers in New York.

See all obstetrics & gynecology providers in New York

Medicare billing

Part B allowed, 2024
$9,477
Medicare patients
71
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol201$21,572
Clobetasol Propionate33$847
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip45$753
Alendronate Sodium74$638
NitrofurantoinNitrofurantoin Macrocrystal11$145
Ibandronate Sodium13$144
Alprazolam18$59

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in West Seneca

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →